You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Before your child receives Infanrix-IPV+Hib

Below you can find information about when Infanrix-IPV+Hib should not be given, and other warnings.

Infanrix-IPV+Hib should not be given if:

  • your child is allergic to Infanrix-IPV+Hib or any of the ingredients in the vaccine (please see the Infanrix-IPV+Hib Patient Information Leaflet (PIL) for details of these)
  • your child experienced problems with the nervous system within 7 days after vaccination against whooping cough
  • your child has a severe infection with a high temperature, over 38°C
  • A minor infection such as a cold should not be a problem, but please talk to your doctor or pharmacist first.

Talk to your doctor or pharmacist if:

  • Any problems have occurred after previous doses of Infanrix-IPV+Hib or another vaccine against whooping cough, especially:
  1. A high temperature within 48 hours of vaccination (over 40°C).
  2. A collapse or ‘shock-like’ state within 48 hours of vaccination.
  3. Persistent crying lasting over three hours within 48 hours of vaccination.
  4. Seizures or fits with or without a high temperature within three days of having the vaccine.
  • Your child is suffering from an undiagnosed or progressive brain disease or uncontrolled epilepsy. Vaccination can be carried out after the disease has been controlled.
  • Your child has a tendency toward seizures or fits due to a fever, or if there is family history of this.
  • Your child has a bleeding problem or bruises easily.

If you are not sure, it is best to talk to your nurse, doctor or pharmacist before vaccination.

Fainting can occur before or following needle injection.

Other medicines and Infanrix-IPV+Hib

Your child can receive Infanrix-IPV+Hib at the same time as other childhood vaccines. A different limb will be used for each vaccine.

Tell your doctor or pharmacist if your child is taking, has recently taken or might take any other medicines.

In particular tell your doctor or pharmacist if your child is taking medicines to fight infection that might affect the immune system. Infanrix-IPV+Hib may not work as well if your child is taking these medicines.

Please see the Infanrix-IPV+Hib Patient Information Leaflet (PIL) for more information.

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at:
By reporting side effects you can help provide more information on the safety of this medicine.

Infanrix-IPV+Hib is a registered trademark of the GlaxoSmithKline Group of Companies

 LS: last updated December 2015: UK/VAC/0019/14(1)h